Pulse Biosciences Return on Investment 2016-2025 | PLSE
Current and historical return on investment (ROI) values for Pulse Biosciences (PLSE) over the last 10 years.
| Pulse Biosciences ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2025-09-30 | $-0.08B | 0.00% | |
| 2025-06-30 | $-0.07B | 0.00% | |
| 2025-03-31 | $-0.06B | 0.00% | |
| 2024-12-31 | $-0.06B | 0.00% | |
| 2024-09-30 | $-0.05B | 0.00% | |
| 2024-06-30 | $-0.05B | 0.00% | |
| 2024-03-31 | $-0.05B | 0.00% | |
| 2023-12-31 | $-0.04B | -325.93% | |
| 2023-09-30 | $-0.04B | -136.75% | |
| 2023-06-30 | $-0.05B | -100.00% | |
| 2023-03-31 | $-0.05B | $0.05B | -108.51% |
| 2022-12-31 | $-0.06B | $0.06B | -173.13% |
| 2022-09-30 | $-0.06B | $0.07B | -360.56% |
| 2022-06-30 | $-0.06B | 0.00% | |
| 2022-03-31 | $-0.06B | 0.00% | |
| 2021-12-31 | $-0.06B | -413.11% | |
| 2021-09-30 | $-0.06B | -406.56% | |
| 2021-06-30 | $-0.06B | -400.00% | |
| 2021-03-31 | $-0.06B | $0.06B | -373.77% |
| 2020-12-31 | $-0.05B | 0.00% | |
| 2020-09-30 | $-0.05B | 0.00% | |
| 2020-06-30 | $-0.05B | 0.00% | |
| 2020-03-31 | $-0.05B | 0.00% | |
| 2019-12-31 | $-0.05B | 0.00% | |
| 2019-09-30 | $-0.04B | 0.00% | |
| 2019-06-30 | $-0.04B | 0.00% | |
| 2019-03-31 | $-0.04B | 0.00% | |
| 2018-12-31 | $-0.04B | 0.00% | |
| 2018-09-30 | $-0.04B | 0.00% | |
| 2018-06-30 | $-0.04B | 0.00% | |
| 2018-03-31 | $-0.03B | 0.00% | |
| 2017-12-31 | $-0.03B | 0.00% | |
| 2017-09-30 | $-0.02B | 0.00% | |
| 2017-06-30 | $-0.02B | 0.00% | |
| 2017-03-31 | $-0.01B | 0.00% | |
| 2016-12-31 | $-0.01B | 0.00% | |
| 2016-09-30 | $-0.01B | 0.00% | |
| 2016-06-30 | $-0.01B | 0.00% | |
| 2016-03-31 | $-0.01B | 0.00% | |
| 2015-12-31 | $-0.01B | 0.00% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.928B | $0.000B |
| Pulse Biosciences, Inc. is a medical device company. It is engaged in developing a novel and proprietary tissue treatment platform using Nano-Pulse Electro-Signaling. NPES provide effective local tumor control and to initiate an adaptive immune response. The company deploy NPES platform applications which include human oncology, dermatology, aesthetics and other minimally invasive applications. Pulse Biosciences, Inc. is based in Burlingame, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $203.769B | 23.72 |
| Intuitive Surgical (ISRG) | United States | $169.156B | 65.25 |
| IDEXX Laboratories (IDXX) | United States | $51.392B | 49.24 |
| Edwards Lifesciences (EW) | United States | $45.321B | 30.39 |
| Alcon (ALC) | Switzerland | $38.763B | 26.12 |
| IQVIA Holdings (IQV) | United States | $30.817B | 16.65 |
| Mettler-Toledo (MTD) | United States | $28.249B | 32.32 |
| DexCom (DXCM) | United States | $27.258B | 37.58 |
| STERIS (STE) | Ireland | $23.929B | 24.19 |
| Waters (WAT) | United States | $22.443B | 29.68 |
| Coloplast (CLPBY) | Denmark | $18.886B | 32.23 |
| Hologic (HOLX) | United States | $16.676B | 17.45 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.939B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.116B | 11.71 |
| Penumbra (PEN) | United States | $13.394B | 94.22 |
| Globus Medical (GMED) | United States | $11.711B | 24.58 |
| SARTORIUS (SSSGY) | Germany | $7.976B | 46.32 |
| Masimo (MASI) | United States | $7.269B | 23.29 |
| Glaukos (GKOS) | United States | $6.520B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $5.967B | 18.96 |
| Teleflex (TFX) | United States | $4.680B | 7.46 |
| TransMedics (TMDX) | United States | $4.429B | 52.47 |
| LivaNova (LIVN) | United Kingdom | $3.551B | 19.18 |
| Integer Holdings (ITGR) | United States | $2.986B | 14.02 |
| Veracyte (VCYT) | United States | $2.756B | 31.41 |
| Elekta AB (EKTAY) | Sweden | $2.223B | 20.79 |
| Nihon Kohden (NHNKY) | Japan | $2.052B | 22.64 |
| Alphatec Holdings (ATEC) | United States | $2.005B | 0.00 |
| UFP Technologies (UFPT) | United States | $1.976B | 26.09 |
| Artivion (AORT) | United States | $1.869B | 85.78 |
| AxoGen (AXGN) | United States | $1.564B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.531B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.284B | 0.00 |
| IRadimed (IRMD) | United States | $1.203B | 57.30 |
| OPKO Health (OPK) | United States | $0.944B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.847B | 4.59 |
| SiBone (SIBN) | United States | $0.682B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.643B | 12.82 |
| Tactile Systems Technology (TCMD) | United States | $0.608B | 35.34 |
| Beta Bionics (BBNX) | United States | $0.583B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.582B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.518B | 0.00 |
| NeuroPace (NPCE) | United States | $0.516B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.504B | 13.12 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.503B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.416B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.415B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.357B | 0.00 |
| RxSight (RXST) | United States | $0.322B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.316B | 52.59 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Sight Sciences (SGHT) | United States | $0.301B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.283B | 0.00 |
| 908 Devices (MASS) | United States | $0.224B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.215B | 0.00 |
| CVRx (CVRX) | United States | $0.174B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.163B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.158B | 0.00 |
| Inogen (INGN) | United States | $0.154B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.150B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.149B | 0.00 |
| LENSAR (LNSR) | United States | $0.147B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.130B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.116B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.109B | 0.00 |
| Hyperfine (HYPR) | United States | $0.101B | 0.00 |
| Neuronetics (STIM) | United States | $0.097B | 0.00 |
| Solana (HSDT) | United States | $0.080B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.080B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| InspireMD (NSPR) | United States | $0.069B | 0.00 |
| Accuray (ARAY) | United States | $0.068B | 0.00 |
| DarioHealth (DRIO) | United States | $0.067B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.059B | 0.00 |
| Positron (POSC) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.046B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.046B | 0.00 |
| Precision Optics (POCI) | United States | $0.046B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.025B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.024B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.016B | 0.00 |
| Envoy Medical (COCH) | United States | $0.015B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.012B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.011B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| NexGel (NXGL) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |